Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTED.L Regulatory News (TED)

  • There is currently no data for TED

Form 8.3 - Ted Baker plc

29 Apr 2022 13:15

RNS Number : 9095J
Barclays PLC
29 April 2022
 

FORM 8.3

 

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

 

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

 

MORE

 

Rule 8.3 of the Takeover Code (the "Code")

 

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

TED BAKER PLC

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of

offeror/offeree:

(e)

Date position held/dealing undertaken:

28 April 2022

(f)

In addition to the company in 1(c) above, is the discloser making

NO

disclosures in respect of any other party to the offer?

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

to which the disclosure relates following the dealing (if any)

Class of relevant security:

5p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1)

Relevant securities owned

and/or controlled:

4,472,128

2.42%

1,250,789

0.68%

(2)

Cash-settled derivatives:

3,705,142

2.01%

2,253,912

1.22%

(3)

Stock-settled derivatives (including options)

and agreements to purchase/sell:

0

0.00%

0

0.00%

TOTAL:

8,177,270

4.43%

3,504,701

1.90%

(b)

Rights to subscribe for new securities (including directors and other executive

 

options)

 

Class of relevant security in relation to

 

which subscription right exists

 

Details, including nature of the rights

 

concerned and relevant percentages:

 

 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

Class of relevant

Purchase/sale

Number of

Price per unit

security

securities

5p ordinary

Purchase

66

1.4720 GBP

5p ordinary

Purchase

251

1.4942 GBP

5p ordinary

Purchase

382

1.5111 GBP

5p ordinary

Purchase

1,094

1.4915 GBP

5p ordinary

Purchase

1,582

1.5020 GBP

5p ordinary

Purchase

1,785

1.4982 GBP

5p ordinary

Purchase

2,160

1.4829 GBP

5p ordinary

Purchase

3,189

1.4696 GBP

5p ordinary

Purchase

6,833

1.5008 GBP

5p ordinary

Purchase

13,226

1.4680 GBP

5p ordinary

Purchase

52,914

1.4969 GBP

5p ordinary

Sale

368

1.4760 GBP

5p ordinary

Sale

421

1.5235 GBP

5p ordinary

Sale

817

1.4679 GBP

5p ordinary

Sale

5,066

1.4727 GBP

5p ordinary

Sale

9,449

1.4680 GBP

5p ordinary

Sale

17,548

1.5156 GBP

 

(b)

Cash-settled derivative transactions

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

reference

unit

security

securities

5p ordinary

 SWAP

Long

10

1.4759 GBP

5p ordinary

 SWAP

Long

272

1.5030 GBP

5p ordinary

 SWAP

Long

440

1.5032 GBP

5p ordinary

 SWAP

Long

992

1.4679 GBP

5p ordinary

 SWAP

Long

2,582

1.5038 GBP

5p ordinary

 CFD

Long

4,316

1.5124 GBP

5p ordinary

 SWAP

Long

8,713

1.4680 GBP

5p ordinary

 SWAP

Long

10,717

1.5194 GBP

5p ordinary

 SWAP

Short

1,582

1.5020 GBP

5p ordinary

 SWAP

Short

1,785

1.4982 GBP

5p ordinary

 SWAP

Short

2,520

1.5117 GBP

5p ordinary

 CFD

Short

4,444

1.4783 GBP

5p ordinary

 SWAP

Short

8,888

1.4680 GBP

5p ordinary

 SWAP

Short

13,810

1.4942 GBP

5p ordinary

 SWAP

Short

14,585

1.4998 GBP

5p ordinary

 SWAP

Short

27,642

1.4980 GBP

 

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

date

money

relevant

selling,

securities

per unit

paid/

security

varying etc

to which

received

option

per unit

relates

(ii)

Exercising

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

securities

unit

(d)

Other dealings (including subscribing for new securities)

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the person making the disclosure and any party

to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

(c)

Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

29 Apr 2022

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETBDGDSDBDDGDC
Date   Source Headline
18th Mar 20228:20 amRNSDirector/PDMR Shareholding
18th Mar 20227:00 amRNSStatement re Possible Offer
7th Mar 20221:01 pmRNSHolding(s) in Company
23rd Feb 20227:00 amRNSQ4 2022 / Pre-close trading update
17th Dec 20213:04 pmRNSBoard composition
6th Dec 20217:00 amRNSJohn Barton
1st Dec 20214:56 pmRNSTotal Voting Rights
11th Nov 202110:48 amRNSReplacement Interim Results
11th Nov 20217:00 amRNSInterim Results
5th Nov 202112:04 pmRNSDirectorate Change
2nd Nov 20213:13 pmRNSBlock listing Interim Review
6th Oct 20214:17 pmRNSDirector/PDMR Shareholding
4th Oct 20217:00 amRNSNew Joint Broker
7th Sep 20217:00 amRNSQ2 Trading Update
4th Aug 20217:00 amRNSDirectorate Change
3rd Aug 202111:22 amRNSDirector/PDMR Shareholding
28th Jul 20213:12 pmRNSNotice of Results
28th Jul 20217:00 amRNSNotice of Q2 Trading Update
23rd Jul 20217:00 amRNSNew Global HQ
28th Jun 20217:00 amRNSNotice of AGM
17th Jun 20217:00 amRNSHolding(s) in Company
14th Jun 20217:00 amRNSFinal Results
9th Jun 20213:11 pmRNSChange to Full Year Results Date
25th May 20217:00 amRNSSuccessful bank refinancing
24th May 20217:00 amRNSChange to Full Year Results Date
13th May 20217:00 amRNSHolding(s) in Company
6th May 20212:54 pmRNSBlock listing Interim Review
29th Apr 202110:55 amRNSHolding(s) in Company
11th Mar 20217:00 amRNSTed Baker announces new territory licence deals
24th Feb 202112:30 pmRNSAdditional Listing
11th Feb 20217:00 amRNSNotice of Results
4th Feb 202110:01 amRNSTotal Voting Rights
8th Jan 20213:47 pmRNSNotice of Results
16th Dec 20206:35 pmRNSDirector/PDMR Shareholding
7th Dec 20207:00 amRNSInterim Results
10th Nov 20207:00 amRNSChange to Interim Results Date
3rd Nov 20205:07 pmRNSBlock listing Interim Review
2nd Nov 202011:49 amRNSHolding(s) in Company
26th Oct 202010:50 amRNSDirector/PDMR Shareholding
14th Oct 202011:31 amRNSNotice of Results
7th Oct 20204:56 pmRNSHolding(s) in Company
6th Oct 20202:34 pmRNSTotal Voting Rights
30th Sep 202010:17 amRNSDirector/PDMR Shareholding
4th Sep 20202:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20204:26 pmRNSDirector/PDMR Shareholding
1st Sep 202010:10 amRNSDirectorate Change
18th Aug 20205:13 pmRNSDirector/PDMR Shareholding
4th Aug 202011:58 amRNSTotal Voting Rights
24th Jul 20205:54 pmRNSHolding(s) in Company
21st Jul 202012:17 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.